Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

6.770
-0.170-2.45%
Volume:853.00K
Turnover:5.77M
Market Cap:5.52B
PE:-17.26
High:6.930
Open:6.940
Low:6.680
Close:6.940
52wk High:12.230
52wk Low:3.910
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:1.45
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.392
ROE:-7.76%
ROA:-5.07%
PB:1.33
PE(LYR):-17.26
PS:8.92

Loading ...

SHANDONG XINHUA (00719) Unit Secures Drug Registration Certificate for Ibuprofen Granules

Stock News
·
Yesterday

Kaisa Health Shares Surge Over 40% Against Market Trend on Planned Acquisition of Qinghai Pharmaceutical

Stock News
·
Yesterday

AI Biotech Funding Surge: Valuations Peak as Commercialization Phase Arrives, But Profitability Remains Distant

Deep News
·
Mar 20

Final Hearing Scheduled for Hainan Poly Pharm Investor Compensation Case with Initial Victory Secured

Deep News
·
Mar 19

Kaisa Group to Divest 30.121% Effective Stake in Qinghai Pharmaceutical

Stock News
·
Mar 18

Zhengda Tianqing's Xie Chengrun: Global Recognition Grows for Domestic Innovative Drugs, U.S. Multinational Pharma Firms Flock to China for Acquisitions

Deep News
·
Mar 17

ASCLETIS-B Selects Oral Amylin Receptor Agonist ASC39 as Clinical Candidate, Demonstrating Eloralintide-Like Selectivity and Efficacy in Preclinical Models

Stock News
·
Mar 17

PEGBIO CO-B (02565) Enters Exclusive Commercialization Pact with Tengrui Pharma for Paidakang in Mainland China, Targeting Over RMB 10 Billion in Cumulative Sales and Receiving Approximately HK$140 Million in Rights Payment

Stock News
·
Mar 16

XTALPI Shares Surge Over 4% as First Annual Profit in 2025 Highlights Value of Unique AI Drug Platform

Stock News
·
Mar 16

China's CCTV 3.15 Gala Highlights Jinshan Pharmaceutical, Controller Xia Yong Serves as Vice President of Sichuan Entrepreneurs Association

Deep News
·
Mar 15

Military Procurement Implements Routine "Piercing" Sanctions: Qilu Pharmaceutical Banned, Compliance Risks for Drug Firms Escalate to Group Level

Deep News
·
Mar 12

Investors Prevail in Compensation Claim Against Hainan Poly Pharm. Despite Delisting

Deep News
·
Mar 12

Ocumension Therapeutics board to review annual results and consider final dividend

Reuters
·
Mar 10

Compensation Analysis of Eight Global Pharmaceutical CEOs in 2025

Deep News
·
Mar 10

ASCLETIS-B's Long-Acting GLP-1 Candidate Shows Promising Weight Loss in U.S. Phase II Trial

Stock News
·
Mar 10

Deepening Integration of Hunan and Hainan Strengths to Access Broader Global Markets, Says NPC Deputy Tang Yue

Deep News
·
Mar 10

Analyst Optimism Drives Surge in Cenotron Pharma Shares

Deep News
·
Mar 10

Guotai Haitong: AI-Driven Drug Development Advances with Accelerated MNC Adoption

Stock News
·
Mar 09

Zealand Pharma Stock Plummets 35% on Disappointing Drug Trial Results

Deep News
·
Mar 07

Hanfang Pharmaceutical's IPO: Flagship Product Peaks, New Drugs Offer No Quick Fix; Brothers with 100% Control Issue Large Dividends Before Listing

Deep News
·
Mar 06